This inventor holds 5 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: University of Ghent, Aphea.bio Nv, Fundación Centro De Excelencia En Investigación De Medicamentos Innovadores En Andalucía, Medina. Active years: 2007-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 505 
2 out of 3 
1 out of 1 Years Active: 2007-2026
Title: Isabel Vercauteren: Innovator in Vaccine Development
Introduction
Isabel Vercauteren is a prominent inventor based in Woubrechtegem, Belgium. She has made significant contributions to the field of vaccine development, particularly through her innovative research and patents. With a total of 5 patents, her work focuses on nucleic acid sequences and their applications in immunology.
Latest Patents
One of her latest patents is the Ostertagia vaccine, which relates to nucleic acid sequences encoding a 30 kD lipoprotein. This invention encompasses parts of such nucleic acid sequences that encode immunogenic fragments of lipoproteins. It also includes DNA fragments, recombinant DNA molecules, live recombinant carriers, and host cells that comprise these nucleic acid sequences. The invention further extends to vaccines that utilize these sequences and components, as well as diagnostic kits that incorporate nucleic acids, lipoproteins, or antibodies against such lipoproteins.
Another significant patent under her name also pertains to the Ostertagia vaccine, focusing on nucleic acid sequences encoding proteins and their immunogenic fragments. This patent similarly covers the use of these proteins in vaccines and diagnostic applications, highlighting the versatility and importance of her research in the field.
Career Highlights
Isabel Vercauteren is affiliated with Universiteit Gent, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of vaccine mechanisms and improving immunological responses.
Collaborations
Throughout her career, Isabel has collaborated with notable colleagues, including Edwin Claerebout and Peter Geldhof. These partnerships have enhanced her research capabilities and contributed to the success of her innovative projects.
Conclusion
Isabel Vercauteren stands out as a key figure in vaccine innovation, with her patents reflecting her dedication to advancing medical science. Her contributions are vital for the development of effective vaccines and diagnostic tools.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile